To explore the mechanisms involved in the efficacy of IFX, we performed DSS-induced colitis in WT and AnxA1−/− C57BL6 mice and followed up to the late phase of the disease (Figure 2 and Supplementary Figures 3, 4). This evidence concerns the gene ANXA1 and colitis.